Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - ADOLOR CORP | a10-19625_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 19, 2010
Adolor Corporation
(Exact name of registrant as specified in its charter)
|
Delaware |
|
000-30039 |
|
31-1429198 |
|
(State or other jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
|
of incorporation) |
|
|
|
Identification No.) |
|
700 Pennsylvania Drive, Exton, PA |
|
19341 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (484) 595-1500
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On October 19, 2010, Adolor Corporation (the “Company”) issued a press release announcing the initiation of a Phase 2 proof-of-concept study of ADL5945 in patients suffering from opioid-induced constipation (OIC).
A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
|
(d) |
Exhibits. |
|
|
|
|
|
|
|
|
|
Exhibit No. |
|
Description of Document |
|
|
99.1 |
|
Press Release of the Company dated October 19, 2010 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
ADOLOR CORPORATION |
|
|
|
|
|
|
|
|
|
|
|
By |
/s/ John M. Limongelli |
|
|
Name: |
John M. Limongelli |
|
|
Title: |
Sr. Vice President, General Counsel and Secretary |
Dated: October 20, 2010